NFE2L2 and lung carcinoma: Furthermore, KEAP1/NRF2 mutations in patients with NSCLC seems to correlate with an increase in local recurrence after RT [67] suggesting that KEAP1/NRF2 status is predictive for local recurrence after RT in patients with lung cancer.